Evidence map›Paper›PMID 42756357›Full record

ArticleFood science & nutrition2026

Identification of Antileukemic Compound From Ginger by Integrating UHPLC-MS, Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and In Vitro and In Vivo Experimental Validation.

Mengjun Huang, Jing Liu, Kaixuan Zeng, Lianling Xu, Yangchun Liu, Linyun Xie, Mengni Shi, Yan Zeng, Wenjun Liu, Ling Guo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mengjun HuangNational-Local Joint Engineering Research Center for Innovative Targeted Drugs Chongqing University of Arts and Sciences Chongqing P. R. China.
Jing LiuDepartment of Pediatric Hematologic Oncology and Respiratory Children's Medical Center, The Affiliated Hospital, Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Southwest Medical University Luzhou Sichuan P. R. China.
Kaixuan ZengPediatrics Department Southwest Medical University Luzhou Sichuan P. R. China.ORCID https://orcid.org/0009-0002-0681-5588
Lianling XuPediatrics Department Southwest Medical University Luzhou Sichuan P. R. China.
Yangchun LiuPediatrics Department Southwest Medical University Luzhou Sichuan P. R. China.ORCID https://orcid.org/0009-0006-4091-4829
Linyun XiePediatrics Department Southwest Medical University Luzhou Sichuan P. R. China.
Mengni ShiDepartment of Clinical Medicine, School of Clinical Medicine Southwest Medical University Luzhou Sichuan P. R. China.ORCID https://orcid.org/0009-0007-1062-6209
Yan ZengDepartment of Pediatric Hematologic Oncology and Respiratory Children's Medical Center, The Affiliated Hospital, Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Southwest Medical University Luzhou Sichuan P. R. China.
Wenjun LiuDepartment of Pediatric Hematologic Oncology and Respiratory Children's Medical Center, The Affiliated Hospital, Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Southwest Medical University Luzhou Sichuan P. R. China.ORCID https://orcid.org/0000-0002-7205-0598
Ling GuoDepartment of Pediatric Hematologic Oncology and Respiratory Children's Medical Center, The Affiliated Hospital, Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Southwest Medical University Luzhou Sichuan P. R. China.ORCID https://orcid.org/0000-0003-1986-3175

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute myeloid leukemia (AML) is a prevalent pediatric hematologic malignancy associated with a poor clinical prognosis, largely due to drug-induced toxicity, the emergence of resistance, and frequent disease relapse. Edible plants offer promising complementary therapeutic approaches through their bioactive compounds, which are characterized by favorable safety profiles.

Indexed as

acute myeloid leukemiaarctigeningingermolecular dynamics simulationnetwork pharmacology

Identifiers

PMID42756357
PMCPMC13583061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.